In particular, it could be particularly interesting to focus on the 3′ region of DAG1, corresponding to the α/β-DG interface, the genetic clinical screenings carried out on still unassigned cases of myopathy presenting with symptoms that may suggest the presence of a dystroglycanopathy. Here, DAG1 is linked to myopathy.